SETting the Stage for Cancer Development: SETD2 and the Consequences of Lost Methylation

10.1186/1471-2407-9-290

10.1242/bio.201410991

10.1038/nsmb.2796

10.1074/jbc.M500796200

10.1038/nature14176

10.1038/ng.2814

10.1038/nature11071

10.1016/j.cell.2005.10.023

10.1093/nar/gks1472

10.7554/eLife.02482

10.1158/2159-8290.CD-12-0095

2011, Scientific report, Nat Publ Gr, 12, 463

10.1038/nature08672

10.1038/nature08617

10.1038/nsmb.2314

10.1038/nsmb.2123

10.1074/jbc.M109.089433

10.1002/humu.22090

10.1038/sj.emboj.7601967

10.1126/science.aae0065

2015, Loss of MLH1 confers resistance to PI3Kβ inhibitors in renal clear cell carcinoma with SETD2 mutation, Tumour Biol, 36, 3457, 10.1007/s13277-014-2981-y

10.1073/pnas.1013571108

10.1007/s00401-013-1095-8

10.1126/scisignal.2004088

10.1016/j.str.2013.12.005

10.1056/NEJMoa1113205

10.1002/gcc.22116

10.7554/eLife.06633

10.1016/j.molcel.2014.08.022

10.1371/journal.pone.0018844

10.1016/j.eururo.2012.09.005

10.1158/1078-0432.CCR-12-3886

2015, High-resolution profiling of histone h3 lysine 36 trimethylation in metastatic renal cell carcinoma, Oncogene, 35, 1565

10.1016/j.cell.2012.06.024

10.1136/gutjnl-2015-309482

10.1016/j.cell.2012.08.029

10.1038/ncomms6006

10.1038/ng.3414

10.1038/onc.2015.24

10.1016/j.cell.2005.10.025

10.1073/pnas.1109475108

10.1038/ng.322

10.1128/MCB.23.12.4207-4218.2003

10.1038/ng863

2005, Risk of tumorigenesis in overgrowth syndromes: A comprehensive review, Am J Med Genet-Semin Med Genet, 137C, 53, 10.1002/ajmg.c.30064

10.1186/s13148-015-0091-3

10.1126/science.1232245

10.1074/jbc.M212134200

10.1073/pnas.0506350102

10.1101/gad.1539307

10.1016/j.cell.2013.03.025

10.1158/1078-0432.CCR-14-1773

2016, Functional studies on primary tubular epithelial cells indicate a tumor suppressor role of SETD2 in clear cell renal cell carcinoma, Neoplasia, 18, 339, 10.1016/j.neo.2016.04.005

10.1371/journal.pone.0004886

2016, Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity, Mod Pathol, 29, 1012, 10.1038/modpathol.2016.97

10.1126/science.283.5406.1325

10.1038/nature10860

10.1126/science.aac7272

10.1126/science.1184208

10.1136/jmedgenet-2014-102402

2014, Mutations in epigenetic regulators including SETD2 are gained during relapse in paediatric acute lymphoblastic leukaemia, Nat Commun, 5, 3469, 10.1038/ncomms4469

10.1016/j.molcel.2010.05.011

2010, Evidence for a tumour suppressor function of SETD2 in human breast cancer: A new hypothesis, Anticancer Res, 30, 3309

10.1038/leu.2016.134

10.1016/j.celrep.2014.05.026

2015, Inhibiting WEE1 selectively kills histone H3K36me3-deficient cancers by dNTP starvation, Cancer Cell, 28, 557, 10.1016/j.ccell.2015.09.015

10.1371/journal.pgen.1002717

10.1038/nsmb.1659

10.1038/nature10833

10.1038/nature11282

10.1038/ng.3382

10.1101/gr.158253.113

10.1016/S0378-1119(99)00506-5

10.1002/(SICI)1098-1004(1998)12:6<417::AID-HUMU8>3.0.CO;2-K

10.1128/MCB.22.5.1298-1306.2002

10.1016/j.ccr.2012.08.024

10.1074/jbc.M504012200

2010, Mechanism and regulation of DNA end resection in eukaryotes, Crit Rev Biochem Mol Biol, 51, 195

10.1038/ng.3409

10.1038/nature11252

10.1038/nature12222

10.1056/NEJMoa1301689

10.1038/nature13480

10.1038/nature12965

10.1038/nature13385

10.1038/nature12113

10.1056/NEJMoa1505917

2016, Dynamic reprogramming of DNA methylation in SETD2-deregulated renal cell carcinoma, Oncotarget, 7, 1927, 10.18632/oncotarget.6481

10.1136/jmedgenet-2015-103638

10.1158/2159-8290.CD-14-0623

10.1038/nature11326

10.1038/nrm3274

2016, Prognostic value of SETD2 expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors, J Urol, 195, 1363

10.1038/ncomms7744

10.1038/ng.1102

10.1038/ng.2938

2015, miR-106b-5p targets tumor suppressor gene SETD2 to inactive its function in clear cell renal cell carcinoma, Oncotarget, 6, 4066, 10.18632/oncotarget.2926

10.1101/gad.1055503

10.1016/j.cellsig.2008.05.012

10.1038/emboj.2011.91

10.1016/j.ccr.2010.12.014

10.1101/gad.1720008

10.1016/j.ccr.2009.12.040

10.1074/jbc.M808431200

10.1038/327721a0

10.1093/nar/gkl989

10.1038/nature10725

2014, H3K36 histone methyltransferase Setd2 is required for murine embryonic stem cell differentiation toward endoderm, Cell Rep, 8, 1989, 10.1016/j.celrep.2014.08.031

10.1038/ng.2894